Principal Investigators
GRK 2338 project leaders come from 5 different institutions:
- Faculty of Medicine, LMU
- Faculty of Chemistry and Pharmacy, LMU
- Faculty of Medicine, TUM
- CPC Helmholtz Zentrum München
- Bundeswehr Institute of Pharmacology and Toxicology
Prof. Dr. med. Dr. rer. nat. Stefan EngelhardtTechnical University of Munich (TUM) +49 89 4140 3260 |
Prof. Dr. rer. nat. Dr. phil. Christian M. GrimmLMU Munich; University of Oxford; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP +49 89 2180-73811 |
Prof. Dr. med. Amanda Tufman, MD, B.Sc.Department of Pneumology University Hospital of Munich Ziemssenstr. 1/5 80336 München +49 89 4400 5 2590 |
|
Prof. Dr. Timo WilleBundeswehr Institute of Pharmacology and Toxicology and Technical University of Munich +49 89 992692 2926 |
|
Prof. Dr. Ali Önder YildirimInstitute of Lung Health and Immunity (LHI) Comprehensive Pneumology Center (CPC) +49-89-3187-4037 |
Prof. Dr. Martin SosDepartment of Translational Oncology, Focus on Reverse Translation, LMU Munich +49 (0)89 4400-43962 |
Prof. Dr. Herbert SchillerInstitute of Lung Biology and Disease (ILBD) Comprehensive Pneumology Center (CPC) +49 89 3187-1194 |
Prof. Dr. rer. nat. Harald JohnBundeswehr Institute of Pharmacology and Toxicology +49-89-992692-2311 |